Life Science Today
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs.
Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
The Niche Episode 016 – Slow, Sickle-Cell, CRO Mergers, Praxis IPO, Wasp Venom
Failures in sickle-cell therapy, CRO mergers in Asia, Praxis IPO, and wasp venom.
Sponsors
https://www.thescopemethod.com
Story References
https://novotech-cro.com/news/asia-pacific-has-record-year-clinical-trials-according-novotech
https://investors.praxismedicines.com/press-releases
https://www.pnas.org/content/early/2020/10/07/2012379117
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 015 – CRISPR, Tinnitus, Takeda, and Political-Science
Nobel prizes, clinical trials for tinnitus, Takeda’s billion-dollar deal, and the White House keeps science political
Sponsors
https://www.thescopemethod.com
Story References
https://www.nobelprize.org/prizes/chemistry/2020/summary/
https://stm.sciencemag.org/content/12/564/eabb2830
https://www.nytimes.com/2020/10/05/us/politics/coronavirus-vaccine-guidelines.html
https://www.businesswire.com/news/home/20201008005340/en/
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 014 – Bristol Myers, Trump, NIH, and Sophia Genetics
Bristol Myers strikes a $13 billion deal, presidential experiments, the NIH funds under-represented testing, and Sophia Genetics raises $110 million.
Sponsors
https://www.thescopemethod.com
Story References
https://www.businesswire.com/news/home/20201005005381/en/Bristol-Myers-Squibb-to-Acquire-MyoKardia-for-13.1-Billion-in-Cash
https://www.sciencemag.org/news/2020/10/heres-what-known-about-president-donald-trump-s-covid-19-treatment
https://www.nih.gov/news-events/news-releases/nih-assess-expand-covid-19-testing-underserved-communities
https://www.sophiagenetics.com/en_US/news/media-mix/details/news/sophia-genetics-raises-110-million-in-oversubscribed-new-funding-round.html
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 013 – Alzheimer’s, COVID19, AKG, Vitamin D, and Gene Therapy
Another Alzheimer’s failure, COVID19 updates, two stories in the supplements space, and Taysha goes public.
Sponsors
https://www.thescopemethod.com
Story References
https://www.medrxiv.org/content/10.1101/2020.09.23.20199604v1.full.pdf
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(20)30417-4
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239799
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 012 – Probiotics, Lipid Nanoparticles, Transparency, and Immuno-therapy
Finch does probiotics the expensive way, lipid nanoparticles, a followup on transparency, and LAVA gains immuno-therapy support.
Sponsors
https://www.thescopemethod.com
https://finchtherapeutics.com/blog/finch-therapeutics-announces-90-million-financing
https://www.modernatx.com/sites/default/files/mRNA-1273-P301-Protocol.pdf
Music by Luke Goodson
The Niche Episode 011 – AstraZeneca, Satsuma Pharmaceuticals, and Orasis Pharmaceuticals
This week, vaccines and shark statistics, are noses the ultimate pipedream, and eye drops to replace eye-glasses.
Sponsors
https://www.thescopemethod.com
Story References
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
Responses